Hydrochloric Acid → N-(1-(6-Chloro-2,3-dihydrobenzo[b][1,4]dioxin-8-yl)ethyl)-2-(methylsulfonyl)-5-(piperazin-1-yl)benzenamine hydrochloride
반응식
[Cl:1][C:2]1[CH:11]=[C:10]([CH:12]([NH:14][C:15]2[CH:20]=[C:19]([N:21]3[CH2:26][CH2:25][NH:24][CH2:23][CH2:22]3)[CH:18]=[CH:17][C:16]=2[S:27]([CH3:30])(=[O:29])=[O:28])[CH3:13])[C:5]2[O:6][CH2:7][CH2:8][O:9][C:4]=2[CH:3]=1.Cl>ClCCl.C(OCC)C>[ClH:1].[Cl:1][C:2]1[CH:11]=[C:10]([CH:12]([NH:14][C:15]2[CH:20]=[C:19]([N:21]3[CH2:22][CH2:23][NH:24][CH2:25][CH2:26]3)[CH:18]=[CH:17][C:16]=2[S:27]([CH3:30])(=[O:29])=[O:28])[CH3:13])[C:5]2[O:6][CH2:7][CH2:8][O:9][C:4]=2[CH:3]=1참가 물질
5
반응물 2
생성물 1
시약·촉매·용매 2
실험 절차
A solution of N-(1-(6-chloro-2,3-dihydrobenzo[b][1,4]dioxin-8-yl)ethyl)-2-(methylsulfonyl)-5-(piperazin-1-yl)benzenamine (50.0 mg, 0.11 mmol) in anhydrous dichloromethane (1 mL) was cooled to 0° C. and HCl (0.12 mL of a 1 M solution in diethyl ether, 0.12 mmol) was added. The mixture was allowed to stir for 30 min. The solvent was removed by rotary evaporation, more diethyl ether was added to precipitate the salt. After removal of solvent by rotary evaporation the desired product was collected (53 mg, 99%). 1H NMR (400 MHz, CD3OD): δ 7.55 (d, 1H), 6.87 (d, 1H), 6.76 (d, 1H), 6.40 (dd, 1H), 6.02 (d, 1H), 4.84 (m, 1H), 4.33 (m, 2H), 4.27 (m, 2H), 4.43 (m, 4H), 3.30 (m, 4H), 3.07 (s, 3H), 1.54 (d, 3H); MS (ESI) m/z: 452.3 (M++1).
후처리
- customThe solvent was removed by rotary evaporation, more diethyl ether
- additionwas added
- customto precipitate the salt
- customAfter removal of solvent
- customby rotary evaporation the desired product
- customwas collected (53 mg, 99%)
출처 및 근거
- ORD 기록
- ord-3ddacbc5b35c4c938eb21c63726d912a
- 출처 데이터셋
- uspto-grants-2013_12
- 특허 번호
- US08604021B2
반응 노트
불러오는 중…